A literature review from 1947 through November 2010 was performed via PubMed using combinations of the search terms transplant, extended spectrum, and ESBL. The publication date was not limited ...

Recently, antibacterial drugs against ESBL-producing Gram-negative ... helix of class C β-lactamases with extended substrate spectrum.

Background: Infections caused by extended-spectrum β-lactamase (ESBL)–producing gram-negative organisms are a growing concern in hospitalized patients. Traditionally, these infections can be ...

American researchers say it could one day represent a potent new tool against antimicrobial-resistant bacteria such as extended-spectrum beta-lactamase (ESBL) producing E. coli. Project leader Dr.

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

including Extended Spectrum Beta-lactamase (ESBL)-expressing Enterobacterales, carbapenem-resistant Enterobacterales (CRE), and multidrug-resistant (MDR) Pseudomonas aeruginosa (MDR-PA), which can ...